Most a short while ago, it has been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to the big range of endogenous opioids. Not like most opioid receptors, this receptor https://werneri987oeg2.theobloggers.com/profile